Drug enterprise risk warning issued 33 pharmaceutical companies on the list!

Pharma Network February 9 - Since the first public release of the Drug Enterprise Risk Warning in November 2020, a total of four issues have been issued, involving 33 pharmaceutical companies on the list.
, China Health Media Group Public Opinion Monitoring Center issued a drug enterprise risk warning alert (2021 issue), the public risk index of the top 10 enterprises.
▍ Reason 1, Guangdong Nanguo Pharmaceutical Co., Ltd. the company produced Malay acid chlorobenamine injection (lot number: 1806251), Simitidine injection (lot number: 1812121), detected clearly visible foreign glass chips, Guangdong Provincial Drug Administration issued a decision on administrative penalties, respectively, fined about 936,000 yuan, 688,000 yuan.
2, Shandong Weizhi Encycloddic Pharmaceutical Co., Ltd. the company produced hydrochloric acid Lidokain injection, "check" item "visible foreign body" does not meet the standard provisions, Shandong Provincial Drug Administration issued a decision on administrative punishment, fined about 495,000 yuan.
3, Yan'an Bikang Pharmaceutical Co., Ltd. the company has the relevant annual report there are major omissions, the relevant annual report has false records, etc. , the China Securities Regulatory Commission Shaanxi Regulatory Bureau decided to the company and related responsible personnel to be fined between 30,000 to 600,000.
4, Kangmei Pharmaceutical Co., Ltd. from 2016 to 2018, the company's actual controller, chairman, etc. through false opening and tampering with value-added tax invoices, forged bank documents, accumulated a total of 88.7 billion yuan in false monetary funds, false income of 27.5 billion yuan, false profits of 3.9 billion yuan.
On May 14, 2020, the CSRC fined Kangmei Pharmaceuticals 600,000 yuan, 21 responsible persons between 100,000 yuan and 900,000 yuan, and six principal responsible persons were banned from the securities market for 10 years to life.
5, Kazakhstan Pharmaceutical Group Pharmaceutical Factory marked as the company's production of "Amoxilin tablets" (lot number: 1903001) does not comply with the regulations.
6, Shandong Kongsan Pharmaceutical Co., Ltd., the company for the use of non-compliant ginseng production of ginseng white art pills (not sold out of the factory), Shandong Provincial Drug Administration issued a decision on administrative penalties fined about 4.166 million yuan.
the company's production of ginseng white art pills in JD.com pharmacy, 1 drug network and other drug e-commerce platform also has poor evaluation, poor evaluation mainly focused on questioning fake and inferior drugs, sales of expired drugs, drug packaging problems.
7, Guangxi Huatianbao Pharmaceutical Co., Ltd. failed to deal with expired drugs in accordance with the provisions of the punishment.
8, Sichuan Dahua West Pharmaceutical Co., Ltd. used aluminum foil for packaging drugs that did not meet national standards.
9, Wuhan Mindetang Chinese medicine drink tablets Co. , Ltd. production and sales do not meet the drug standards clams.
10, Anhui Pharmaceutical Zhiyuan Chinese Medicine Drink Tablets Co., Ltd. marked as the company's production of the dragon (lot number: 200501) does not meet the requirements, non-conforming items as "features", before, Anhui Pharmaceutical Zhiyuan has been punished several times for production violations.
▍ Other issues on the list of small statistics of drug enterprises risk warning tips other periods on the list, as follows: ▍ a total of 33 pharmaceutical companies on the list of pharmaceutical enterprises risk warning issued in November 2020 since the first public release, a total of 4 issues, involving 33 pharmaceutical companies on the Among them: Anhui Pharmaceutical Zhiyuan Chinese Medicine Tablets Co., Ltd., Jining Banger Chinese Medicine Tablets Co., Ltd. each on the list 3 times;
drug enterprise risk warning specific number of times ranked as follows: